Hanmi Pharm Co (XKRX:128940) ROCE % : 2.24% (As of Dec. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Hanmi Pharm Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Hanmi Pharm Co's annualized ROCE % for the quarter that ended in Dec. 2024 was 2.24%.

Hanmi Pharm Co ROCE % Historical Data

The historical data trend for Hanmi Pharm Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hanmi Pharm Co ROCE % Chart

Hanmi Pharm Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

3.37

9.12

11.33

18.22

15.45

Hanmi Pharm Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															21.06	26.67	18.96	13.97	2.24

Hanmi Pharm Co ROCE % Calculation

Hanmi Pharm Co's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	195627.748	/	( ( (1898668.376 - 704762.991)	+	(2020840.494 - 682758.544) )	/ 2 )
	=	195627.748	/	( (1193905.385	+	1338081.95)	/ 2 )
	=	195627.748	/	1265993.6675
	=	15.45 %

Hanmi Pharm Co's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	30126.428	/	( ( (1971126.476 - 623494.789)	+	(2020840.494 - 682758.544) )	/ 2 )
	=	30126.428	/	( ( 1347631.687	+	1338081.95 )	/ 2 )
	=	30126.428	/	1342856.8185
	=	2.24 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

Hanmi Pharm Co (XKRX:128940) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Hanmi Pharm Co ROCE % Related Terms

Thank you for viewing the detailed overview of Hanmi Pharm Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Hanmi Pharm Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hanmi Pharm Co Ltd (XKRX:128940) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

45 Bangi-dong, Songpa, Seoul, Gyeonggi, KOR, 138-724

Website

http://www.hanmi.co.kr

Hanmi Pharm Co Ltd is a Korea-based company, engaged in manufacturing and marketing of medicines, medical supplies and raw materials for medicines. The company makes strenuous and enthusiastic efforts to develop treatments for diabetes, obesity, cancer, autoimmune and rare disease to keep everyone's health and improve their quality of life. The group distributes its products within Korean market and to overseas markets.

Hanmi Pharm Co Headlines

No Headlines